ABT-491 Hydrochloride - CAS 189689-94-9
Catalog number: 189689-94-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Platelet-activating factor receptor (PAF-R)
ABT-491 Hydrochloride is a potent, selective and orally active platelet-activating factor receptor (PAF-R) antagonist (Ki = 0.6 nM in human platelets).
Publictions citing BOC Sciences Products
  • >> More
Colourless oil
4-ethynyl-3-[3-fluoro-4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]benzoyl]-N,N-dimethylindole-1-carboxamide;hydrochloride; ABT 491; ABT-491
Boiling Point:
534.622 ℃ at 760 mmHg
1.143 g/cm3
Canonical SMILES:
1.Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Albert DH1, Magoc TJ, Tapang P, Luo G, Morgan DW, Curtin M, Sheppard GS, Xu L, Heyman HR, Davidsen SK, Summers JB, Carter GW. Eur J Pharmacol. 1997 Apr 23;325(1):69-80.
ABT-491 (4-ethynyl-N, N-dimethyl-3-[3-fluoro-4-[(2-methyl-1H-imidazo-[4,5-c]pyridin-1-yl)methy l]benzoyl]-1H- indole-1-carboxamide hydrochloride) is a novel PAF (platelet-activating factor) receptor antagonist with a K(i) for inhibiting PAF binding to human platelets of 0.6 nM. Binding kinetics of ABT-491 to the PAF receptor is consistent with a relatively slow off-rate of the antagonist when compared to PAF. Inhibition of PAF binding is selective and is correlated with functional antagonism of PAF-mediated cellular responses (Ca2+ mobilization, priming, and degranulation). Administration of ABT-491 in vivo leads to potent inhibition of PAF-induced inflammatory responses (increased vascular permeability, hypotension, and edema) and PAF-induced lethality. Oral potency (ED50) was between 0.03 and 0.4 mg/kg in rat, mouse, and guinea-pig. When administered intravenously in these species, ABT-491 exhibited ED50 values between 0.005 and 0.016 mg/kg.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Platelet-activating factor receptor (PAF-R) Products

(CAS: 170499-15-7)

ABT-491, an imidazopyridine derivative, has been found to be a PAF receptor antagonist that was once studied against allergic rhinitis.

CAS 189689-94-9 ABT-491 Hydrochloride

ABT-491 Hydrochloride
(CAS: 189689-94-9)

ABT-491 Hydrochloride is a potent, selective and orally active platelet-activating factor receptor (PAF-R) antagonist (Ki = 0.6 nM in human platelets).

CAS 205654-37-1 CMI-392

(CAS: 205654-37-1)

CMI-392 is a dual antagonist of 5-lipoxygenese (IC50= 100 nM) and platelet-activating factor (PAF) receptor (IC50= 10 nM).

MK 287
(CAS: 135947-75-0)

MK-287 is platelet activating factor (PAF) inhibitor originated by Merck & Co. It can potently inhibit [3H]C18-PAF binding to human platelet, PMN (polymorphonuc...

(CAS: 143901-35-3)

Aglafoline, isolated from Aglaia elliptifolia Merr, is a selective PAF-induced platelet aggregation inhibitor. And studies have shown that because aglafoline bl...

CAS 115621-84-6 PAF-AN-1

(CAS: 115621-84-6)

PAF-AN-1 is a platelet activating factor receptor (PAF) antagonist.

CAS 15291-76-6 Ginkgolide C

Ginkgolide C
(CAS: 15291-76-6)

Ginkgolide C, extracted from the Ginkgo biloba leaves, a traditional Chinese medicine, significantly increases the formation of cyclic adenosine monophosphate (...

CAS 122957-06-6 Modipafant

(CAS: 122957-06-6)

This active molecular is a dihydropyridine Platelet-Activating Factor (PAF) antagonist under the development of Pfizer. In Sep 2015, treatment for Asthma in USA...

Chemical Structure

CAS 189689-94-9 ABT-491 Hydrochloride

Quick Inquiry

Verification code

Featured Items